{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T09:05:53Z","timestamp":1777021553089,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"China Russian France International Cooperation Research Project","award":["87E2A0313397"],"award-info":[{"award-number":["87E2A0313397"]}]},{"name":"Xinjiang Uygur Autonomous Region science and technology personnel training project","award":["qn2015jg005"],"award-info":[{"award-number":["qn2015jg005"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81360668"],"award-info":[{"award-number":["81360668"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangxi national traditional medicine Collaborative innovation of China","award":["JXXT201404001"],"award-info":[{"award-number":["JXXT201404001"]}]},{"name":"Xinjiang Traditional Chinese medicine new drug research and development projects","award":["Q2015-01-06"],"award-info":[{"award-number":["Q2015-01-06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12906-017-1685-4","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T07:49:36Z","timestamp":1491551376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Enhanced efficacy with reduced toxicity of chemotherapy drug 5-fluorouracil by synergistic treatment with Abnormal Savda Munziq from Uyghur medicine"],"prefix":"10.1186","volume":"17","author":[{"given":"Tao","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutalifu","family":"Aimaiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deqi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilinuer","family":"Maimaitiyiming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdiryim","family":"Yusup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halmurat","family":"Upur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainiwaer","family":"Aikemu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"issue":"2","key":"1685_CR1","first-page":"1","volume":"11","author":"YL Qiao","year":"2015","unstructured":"Qiao YL, Zhao YQ. Epidemiology and prevention of cervical cancer. Chin J Obstet Gynecol Pediatr (Electronic Edition). 2015;11(2):1\u20136.","journal-title":"Chin J Obstet Gynecol Pediatr (Electronic Edition)"},{"issue":"9","key":"1685_CR2","first-page":"641","volume":"25","author":"FF Yin","year":"2015","unstructured":"Yin FF, Wang N, Yu X, Bi XN, Xu XH, Wang YK. The roles ofHPV16E6,E7 andE6\/E7 genes inSTK31 promoter\/exon1 methylation and expression levels in cervical cancer cell lines. Chin Oncol. 2015;25(9):641\u201351.","journal-title":"Chin Oncol"},{"issue":"10","key":"1685_CR3","first-page":"1258","volume":"8","author":"C Zhang","year":"2013","unstructured":"Zhang C. Research review on the toxicity reducing and efficacy enhancing function of Chinese medicine combined with chemotherapy in treating advanced lung cancer. World Chin Med. 2013;8(10):1258\u201360.","journal-title":"World Chin Med"},{"issue":"3","key":"1685_CR4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF02836399","volume":"10","author":"HS Lin","year":"2004","unstructured":"Lin HS, Yang YF, Li PP, Hao YX. Approaches of toxicity-reducing and efficacy-enhancing in tumor patients treated with radio- and chemotherapy. Chin J Integr Med. 2004;10(3):162\u20139.","journal-title":"Chin J Integr Med"},{"issue":"10","key":"1685_CR5","first-page":"68","volume":"32","author":"R Aizezi","year":"2014","unstructured":"Aizezi R, Tayir P, Aikemu A, Aper A. Zuliayati, Lu M, Tuerxun T, Upur H. Synergistic attenuation of abnormal Savda Munziq combination with 5-fluorouracil on Transplantated EAC tumor. Sci Technol Rev. 2014;32(10):68\u201373.","journal-title":"Sci Technol Rev"},{"issue":"1","key":"1685_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-12-157","volume":"12","author":"A Aikemu","year":"2012","unstructured":"Aikemu A, Umar A, Yusup A, Upur H, Berk\u00e9 B, B\u00e9gaud B, Moore N. Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice. BMC Complement Altern Med. 2012;12(1):1\u20137.","journal-title":"BMC Complement Altern Med"},{"key":"1685_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0973-1296.96568","volume":"8","author":"A Aikemu","year":"2012","unstructured":"Aikemu A, Yusup A, Umar A, Berk\u00e9 B, Moore N, Upur H. The impact of the Uighur medicine abnormal savda munziq on antitumour and antioxidant activity in a S180 and Ehrlich ascites carcinoma mouse tumour model. Pharmacogn Mag. 2012;8:141\u20138.","journal-title":"Pharmacogn Mag"},{"issue":"22","key":"1685_CR8","first-page":"22","volume":"51","author":"GN Wang","year":"2011","unstructured":"Wang GN, Li H, Chen KY. Guzalnur\u00b7a. Effects of total phenolics from abnormal savda munziq combined with cisplation, ocetaxd on HeLa cells proliferation and apoptosis. Shandong Med J. 2011;51(22):22\u20134.","journal-title":"Shandong Med J"},{"issue":"09","key":"1685_CR9","first-page":"31","volume":"14","author":"H Mayinur","year":"2007","unstructured":"Mayinur H. The reverse effect of Uygur medicine ASMq on the drug resistance cells of liver cancer. Chin J Inf Tradit Chin Med. 2007;14(09):31\u20133.","journal-title":"Chin J Inf Tradit Chin Med"},{"issue":"08","key":"1685_CR10","first-page":"1255","volume":"34","author":"KY Chen","year":"2011","unstructured":"Chen KY, Tangnur A, Wang GN, Guzalnur A. The effect of Total Phenolics from abnormal Savda Munziq on cervical cancer cell lines. J Chin Med Mater. 2011;34(08):1255\u20139.","journal-title":"J Chin Med Mater"},{"key":"1685_CR11","volume-title":"Graeco-Arab-Uighur medicine","author":"H Upur","year":"2013","unstructured":"Upur H, Dubrovin D, Amat N, Liu W, Moore N, Bauer R, et al. Graeco-Arab-Uighur medicine. USA: Acupress; 2013."},{"key":"1685_CR12","volume-title":"New interpretations of abnormal Savda theory of traditional Uighur medicine","author":"H Upur","year":"2009","unstructured":"Upur H, Yusufu A, Aimaiti N. New interpretations of abnormal Savda theory of traditional Uighur medicine. China, Urumqi: Xinjiang People\u2019s Press; 2009."},{"issue":"1","key":"1685_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-015-0520-z","volume":"15","author":"A Dhakshinamoorthy","year":"2015","unstructured":"Dhakshinamoorthy A, Alvaro M, Garcia H. Anti-carcinogenic effects of the phenolic-rich extract from abnormal Savda Munziq in association with its cytotoxicity, apoptosis-inducing properties and telomerase activity in human cervical cancer cells (SiHa). BMC Complement Altern Med. 2015;15(1):1\u201310.","journal-title":"BMC Complement Altern Med"},{"issue":"7","key":"1685_CR14","first-page":"58","volume":"36","author":"DS Wu","year":"2015","unstructured":"Wu DS, Liu J, Wei D, Zhao DQ, Zhou MT, Feng LP. Study on the anti - tumor activity and Immunomodulatory effect of alcohol extraction of brook anemone. Yunnan J Tradit Chin Med Mater Med. 2015;36(7):58\u201360.","journal-title":"Yunnan J Tradit Chin Med Mater Med"},{"issue":"23","key":"1685_CR15","first-page":"190","volume":"20","author":"BC Peng","year":"2014","unstructured":"Peng BC, Huang J, Li P, Hy J. Studies on antitumor effect and mechanisms of Sophora tonkinensis and its granules. Chin J Exp Tradit Med Formulae. 2014;20(23):190\u20133.","journal-title":"Chin J Exp Tradit Med Formulae"},{"issue":"19","key":"1685_CR16","first-page":"359","volume":"35","author":"XJ Zhang","year":"2014","unstructured":"Zhang XJ, Luan ZZ, Sun XJ, Yang S, et al. Mechanism of attenuation and potentiation of the soybean polysaccharide to antitumor of cyclophosphamide. Sci Technol Food Ind. 2014;35(19):359\u201361.","journal-title":"Sci Technol Food Ind"},{"issue":"6","key":"1685_CR17","first-page":"8551","volume":"8","author":"N Li","year":"2015","unstructured":"Li N, Kong M, Ma T, Gao W, Ma S. Uighur medicine abnormal savda munzip (ASMq) suppresses expression of collagen and TGF-\u03b21 with concomitant induce Smad7 in human hypertrophic scar fibroblasts. Int J Clin Exp Med. 2015;8(6):8551\u201360.","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"1685_CR18","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.18632\/oncotarget.6441","volume":"7","author":"S Kim","year":"2016","unstructured":"Kim S, Lee J, Jeon M, Lee JE, Nam SJ. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-\u03b21 signaling pathway. Oncotarget. 2016;7(2):1544\u201358.","journal-title":"Oncotarget"},{"issue":"2","key":"1685_CR19","first-page":"S280","volume":"10","author":"X He","year":"2015","unstructured":"He X, Qian Y, Cai H, Yang S, Cai J, Wang Z. RhoC is essential in TGF-\u03b21 induced epithelial-mesenchymal transition in cervical cancer cells. Oncol Lett. 2015;10(2):S280\u20133.","journal-title":"Oncol Lett"},{"key":"1685_CR20","doi-asserted-by":"crossref","first-page":"16941","DOI":"10.1038\/srep16941","volume":"5","author":"KM McAndrews","year":"2015","unstructured":"McAndrews KM, McGrail DJ, Ravikumar N, Dawson MR. Mesenchymal stem cells induce directional migration of invasive breast cancer cells through TGF-\u03b2. Sci Rep. 2015;5:16941.","journal-title":"Sci Rep"},{"issue":"40","key":"1685_CR21","doi-asserted-by":"crossref","first-page":"42923","DOI":"10.18632\/oncotarget.5976","volume":"6","author":"WC Chen","year":"2015","unstructured":"Chen WC, Chang YS, Hsu HP, Yen MC, Huang HL, et al. Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer. Oncotarget. 2015;6(40):42923\u201337.","journal-title":"Oncotarget"},{"issue":"11","key":"1685_CR22","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.4161\/cc.4.11.2123","volume":"4","author":"S Bellanger","year":"2005","unstructured":"Bellanger S, Blachon S, Mechali F, Bonne-Andrea C, Thierry F. High-risk but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability. Cell Cycle. 2005;4(11):1608\u201315.","journal-title":"Cell Cycle"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-017-1685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T04:06:10Z","timestamp":1601870770000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-017-1685-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1685"],"URL":"https:\/\/doi.org\/10.1186\/s12906-017-1685-4","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]},"article-number":"201"}}